ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy

ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy

IntroductionThe efficacy of postoperative radiotherapy (PORT) is still unclear in non-small cell lung cancer (NSCLC) patients with pIIIA-N2 disease. Estrogen receptor (ER) was proven significantly associated with poor clinical outcome of male lung squamous cell cancer (LUSC) after R0 resection in ou...

Full description

Bibliographic Details
Main Authors: Xue Yang, Lili Wang, Xiangfeng Jin, Rongjian Xu, Zhuang Yu, Hongmei Li, Haijun Lu, Ning An
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
postoperative radiotherapy
lung squamous cell cancer
stage IIIA-N2
survival
estrogen
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1158104/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1158104/full

Similar Items